Please select the option that best describes you:

Would you use AR-V7 testing to decide second-line androgen receptor-axis-targeted therapy vs chemotherapy for patients who with metastatic castration-resistant prostate cancer?  

If yes, what factors push you to test for AR-V7 or would you test all patients in this clinical scenario?



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Siri Onclogy and hematology Infusion Service
If one looks at the survival in an epic ARV7 + pat...
Sign in or Register to read more

Answer from: Medical Oncologist at Community Practice
Sign in or Register to read more